Allovir Inc Virtual Investor Event Call Transcript
Good morning, everyone, and welcome to AlloVir's first virtual investor event. I'm Sonia Choi, AlloVir's Senior Vice President of Corporate Affairs and Investor Relations and your host for today.
During today's call, AlloVir's Chief Executive Officer Dr. Diana Brainard will provide a corporate update; and Dr. Sanjeet Dadwal, Chief of Infectious Diseases and Professor Of medicine at City of Hope, will walk us through the positive preliminary data from the Phase 2 posoleucel multi-virus prevention study that were reported at the American Society of Hematology Annual Meeting over the weekend.
Following Dr. Brainard and Dr. Dadwal's presentations, we will open the call up for Q&A. Vikas Sinha, AlloVir's Chief Financial Officer, and Jeroen van Beek, our Chief Commercial Officer, will join our presenters and will be available for questions. We encourage our covering research analysts and investors to take the opportunity to ask questions during the Q&A portion of the call. (Operator instructions)
Before I turn the call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
